Literature DB >> 18506085

Combined expression of transcription factors induces AR42J-B13 cells to differentiate into insulin-producing cells.

Takeshi Ogihara1, Yoshio Fujitani, Toyoyoshi Uchida, Rei Kanno, Jong Bock Choi, Takahisa Hirose, Ryuzo Kawamori, Hirotaka Watada.   

Abstract

Neurogenin 3 (Ngn3) is a transcription factor that regulates an initial step of differentiation from uncommitted pancreatic progenitors into endocrine cells. Additional transcription factors are required for complete differentiation into mature pancreatic beta cells. In this study, we established an in vitro model system of beta-cell differentiation by adenovirus-mediated expression of several transcription factors in AR42J-B13 cells, a pancreatic progenitor-like cell line derived from exocrine pancreas. Exogenous expression of Ngn3 in AR42J-B13 cells induced expression of Nkx2.2, Pax4, and Pax6, which are all essential for beta-cell differentiation in mouse embryos. However, Ngn3 did not induce more downstream regulators of beta-cell differentiation, Nkx6.1 and Maf A. Coexpression of Nkx6.1 and Ngn3 induced endogenous expression of the insulin 2 gene, while coexpression of Maf A and Ngn3 induced both insulin 1 and 2 genes in AR42J-B13 cells. Our data demonstrated that Ngn3 expressed together with Nkx6.1 or MafA induces AR42J-B13 cells to differentiate into insulin-producing cells, supporting the use of these cells as a model system for studying beta-cell differentiation in vitro.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18506085     DOI: 10.1507/endocrj.k07e-169

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  7 in total

1.  Functional role of an islet transcription factor, INSM1/IA-1, on pancreatic acinar cell trans-differentiation.

Authors:  Tao Zhang; Nicolle A Saunee; Mary B Breslin; Kejing Song; Michael S Lan
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

2.  PAX4 Gene Transfer Induces α-to-β Cell Phenotypic Conversion and Confers Therapeutic Benefits for Diabetes Treatment.

Authors:  Yanqing Zhang; Genevieve E Fava; Hongjun Wang; Franck Mauvais-Jarvis; Vivian A Fonseca; Hongju Wu
Journal:  Mol Ther       Date:  2015-10-05       Impact factor: 11.454

Review 3.  MafA and MafB activity in pancreatic β cells.

Authors:  Yan Hang; Roland Stein
Journal:  Trends Endocrinol Metab       Date:  2011-06-28       Impact factor: 12.015

4.  RBM4 promotes pancreas cell differentiation and insulin expression.

Authors:  Jung-Chun Lin; Yu-Ting Yan; Wen-Kou Hsieh; Pey-Jey Peng; Chun-Hao Su; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

5.  Reprogramming of pancreatic exocrine cells towards a beta (β) cell character using Pdx1, Ngn3 and MafA.

Authors:  Ersin Akinci; Anannya Banga; Lucas V Greder; James R Dutton; Jonathan M W Slack
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

6.  Identification of miRNAs Involved in Reprogramming Acinar Cells into Insulin Producing Cells.

Authors:  Joan Teichenne; Meritxell Morró; Alba Casellas; Veronica Jimenez; Noelia Tellez; Adrien Leger; Fatima Bosch; Eduard Ayuso
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

7.  Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cells.

Authors:  Maria João Lima; Kenneth R Muir; Hilary M Docherty; Robert Drummond; Neil W A McGowan; Shareen Forbes; Yves Heremans; Isabelle Houbracken; James A Ross; Stuart J Forbes; Philippe Ravassard; Harry Heimberg; John Casey; Kevin Docherty
Journal:  Diabetes       Date:  2013-04-22       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.